Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 5:13 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1777–1800 of 3,255 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Device Clear all

Conditions: Intracranial Aneurysm
Interventions: CODMAN ENTERPRISE® Vascular Reconstruction Device and Delivery System; Device
Lead sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.; Industry
Eligibility: 21 Years to 70 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 11
States / cities: Englewood, Colorado • Gainesville, Florida • Jacksonville, Florida + 8 more

Conditions: Lung Diseases
Interventions: tPAD Device, PARI LC Star Nebulizer; Device
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 65 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Breast Cancer, Breast Carcinoma, Cancer of the Breast, Malignant Neoplasm of Breast
Interventions: Expression Networks for highLIGHting Tumor vulnerabilities (ENLIGHT), TruSight(R) Oncology 500, TruSeq Matched Tumor Normal Whole Exome Sequencing Assay; Device
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 120 Years
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Prostate Cancer
Interventions: MRI-guided Transurethral Ultrasound Ablation; Device
Lead sponsor: Profound Medical Inc.; Other
Eligibility: 45 Years to 80 Years · Male only
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2028
U.S. locations: 8
States / cities: Los Angeles, California • New Haven, Connecticut • Chicago, Illinois + 5 more

Conditions: Cardiopulmonary Disease
Interventions: Noninterventional and noninvasive; Diagnostic Test
Lead sponsor: Analog Device, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Venous Thromboses, Venous Stasis
Interventions: OsciPulse system, Reference Therapy 1, Refence Therapy 2; Device
Lead sponsor: OsciFlex LLC; Industry
Eligibility: 40 Years to 90 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Osteoarthritis, Knee
Interventions: GID SVF-2 Device System; Device
Lead sponsor: GID BIO, Inc.; Industry
Eligibility: 35 Years to 85 Years
Enrollment: 114 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 9
States / cities: Sacramento, California • Coral Springs, Florida • New Orleans, Louisiana + 6 more

Conditions: Pressure Ulcer, Pressure Injury, Falls Injury
Interventions: Masimo Centroid System; Device
Lead sponsor: Masimo Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Hypertension, Pulmonary, Lung Diseases, Interstitial
Interventions: Inhaled Nitric Oxide (iNO); Device
Lead sponsor: Third Pole Therapeutics, Inc.; Industry
Eligibility: 22 Years to 84 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 3
States / cities: Tampa, Florida • Cincinnati, Ohio • Charleston, South Carolina

Conditions: Liver Cancer
Interventions: TriNav, Traditional Delivery, Doxorubicin; Device · Drug
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Chronic Disease of Cardiovascular System
Interventions: Symptoms of chronic illness.; Other
Lead sponsor: Aventyn, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Timeline: 2018
U.S. locations: 1
States / cities: Chandler, Arizona

Conditions: Peripheral Vascular Disease
Interventions: Absolute Pro™ Peripheral Self-Expanding Stent System; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years to 89 Years
Enrollment: 151 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Santa Clara, California

Conditions: Barrett's Esophagus
Interventions: Experimental OFDI Imaging; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 14 Years to 85 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2030
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Infiltration, Extravasation, IV Infiltration, IV Extravasation, Extravasation of Diagnostic and Therapeutic Materials
Interventions: Not listed
Lead sponsor: ivWatch, LLC; Industry
Eligibility: Up to 12 Years
Enrollment: 139 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Labor Pain, Contraction
Interventions: Fetal Life tocometer device; Device
Lead sponsor: Fetal Life LLC; Industry
Eligibility: 20 Years to 40 Years · Female only
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Aneurysm
Interventions: Codman Enterprise 2 Vascular Reconstruction Device; Device
Lead sponsor: Methodist Health System; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2026
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Major Depressive Disorder
Interventions: Near-infrared radiation via Transcranial LED Therapy, Sham device; Device
Lead sponsor: Paolo Cassano; Other
Eligibility: 18 Years to 65 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 2
States / cities: Boston, Massachusetts • Chelsea, Massachusetts

Conditions: Wrinkle Reduction
Interventions: nebulyft; Device
Lead sponsor: Hangzhou Rebecca Medical Science and Technology Ltd.; Industry
Eligibility: 25 Years to 65 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: San Gabriel, California

Conditions: Cancer
Interventions: Long-term follow-up of cerena™, Long-term follow-up of attune™; Device
Lead sponsor: Blue Note Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Diabetes Mellitus, Diabetic Retinopathy
Interventions: AEYE-DS Software; Device
Lead sponsor: AEYE Health Inc; Industry
Eligibility: 22 Years and older
Enrollment: 363 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 3
States / cities: Fayetteville, Arkansas • Orlando, Florida • Jackson, Tennessee

Conditions: Body Fat
Interventions: Cutera truSculpt; Device
Lead sponsor: Cutera Inc.; Industry
Eligibility: 24 Years to 60 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Brisbane, California

Conditions: PTSD
Interventions: Prolonged Exposure for Primary Care (PE-PC), Full Prolonged Exposure, Clinician Supported PTSD Coach App; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 430 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 13
States / cities: Baldwin, Michigan • Battle Creek, Michigan • Flint, Michigan + 9 more

Conditions: Degenerative Disc Disease
Interventions: FLXfit 15TM device; Device
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 31 participants
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Dystonia
Interventions: Medtronic Activa Gpi; Device
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 7 Years and older
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: Nashville, Tennessee

Search by objective public record fields.

Study to Evaluate the Safety and Effectiveness of the CODMAN ENTERPRISE® Vascular Reconstruction Device

Evaluation of Regional Lung Deposition of Inhaled Saline Using the tPAD Device

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

Pivotal Study of MRI-guided Transurethral Ultrasound Ablation in Patients With Localized Prostate Cancer

Clinical Validation Study for Noninvasive Cardiopulmonary Management Device

Evaluation of the OsciPulse Rapid Cycling Compression Device Effects on Venous Blood Flow

Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Knee Osteoarthritis

Usability Validation of Patient Monitoring Device for Pressure Injury Prevention and Fall Detection

Early Feasibility Study Evaluating the 3P-100 Device in Subjects With PH-ILD

Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies

Remote Monitoring of Chronic Illness Patients With a IHAP Home Wireless Hub and Vitals Measurements

Trial to Evaluate the Safety & Efficacy of the Absolute Pro™ Peripheral Self-Expanding Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery.

Pilot Study for TCE Imaging of the Esophagus Using an OFDI Capsule With a Compact Imaging System

Monitoring the Peripheral Intravenous Infusion Site for Infiltration and Extravasation

Fetal Life: Smart-Device Based Uterine Activity Monitoring

Enterprise 2 Vascular Reconstruction Device

Transcranial Laser Therapy for Major Depressive Disorder

Assessment of the Safety and Effectiveness of a Micro-RF Skin Treatment Device (nebulyft）

Long-term Follow-up of RESTORE Study

Efficacy and Safety of AEYE-DS Software Device for Automated Detection of Diabetic Retinopathy From Digital Funduscopic Images

Performance Evaluation of the truSculpt Radiofrequency Device for Lipolysis of Abdominal Fat

Testing Adaptive Interventions to Improve Posttraumatic Stress Disorder Treatment Outcomes in Federally Qualified Health Centers

FLXfitTM 15 TLIF Interbody Fusion Device

Humanitarian Device Exemption